Stanley Druckenmiller
TWST icon

Stanley Druckenmiller’s Twist Bioscience TWST Stock Holding History

Stanley Druckenmiller’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.79M Buy
+206,000
New +$9.24M 0.29% 56

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stanley Druckenmiller's TWST Position: Q1 2026 in Review

Stanley Druckenmiller opened a new position in Twist Bioscience (TWST) in Q1 2026: 206,000 shares worth $9.79M. The stake represents 0.29% of the portfolio and ranks #56 among its holdings.

280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Stanley Druckenmiller held 206,000 shares of Twist Bioscience worth $9.79M as of Q1 2026.
  • Twist Bioscience was a new Stanley Druckenmiller position in Q1 2026.
  • Twist Bioscience made up 0.29% of Stanley Druckenmiller's portfolio in Q1 2026, its #56 holding.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Duquesne Family Office's 13F filing for Q1 2026, filed 15 May 2026.